2026 NPPES data Medical Oncology Physician NPI 1073540332 MD
Verify on CMS →

GIAMPAOLO TALAMO, MD

Medical Oncology Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
486
Medicare Part D claims · 125 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.9075/100
▼ 0 pts below national avg 83.1 · [object Object]
Industry payments
$293.17
9 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GIAMPAOLO TALAMO, MD reported a CMS MIPS final score of 82.9075/100 — below the 83.1 national average — and filed 486 Medicare Part D claims in 2023.

82.9075/100
MIPS score · 0 vs avg
486
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GIAMPAOLO TALAMO, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

83 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GIAMPAOLO TALAMO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GIAMPAOLO TALAMO, MD?

Near national average

NPI registry status

Active

Issued 06/26/2006

NPI 1073540332

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

486 29% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

82.9075/100 0.19249999999999545% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in District of Columbia

How Medical Oncology Physician compares to other specialties among District of Columbia providers

District of Columbia providers

Medical Oncology Physician share within District of Columbia

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within District of Columbia

Medicare quality performance — MIPS

GIAMPAOLO TALAMO, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

Near national average
MIPS Final Score
82.9075/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 82.9075/100 vs national avg 83.1

0%100%National avg83%82.9%
MIPS final score (Medical Oncology Physician) — 82.9075/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GIAMPAOLO TALAMO, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 5255 LOUGHBORO RD NW FL 1, WASHINGTON, DC, 20016, with a listed phone of (202) 660-6500. NPI 1073540332 was issued on 06/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TALAMO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 486 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 23% brand-name and 77% generic by claim count, with an opioid prescribing rate of 9.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.9075/100 for the 2023 performance year (Quality 74.0928, Cost 65.9443), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5255 LOUGHBORO RD NW FL 1
WASHINGTON, DC 20016

Provider Details

NPI 1073540332
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 06/26/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.9075
Final Score
Avg: 83.1
74.0928
Quality
65.9443
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where GIAMPAOLO TALAMO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GUTHRIE MEDICAL GROUP PC
SAYRE, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GIAMPAOLO TALAMO, MD. Source: openpaymentsdata.cms.gov.

Total received

$293

Largest payer

Exelixis Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

GIAMPAOLO TALAMO, MD — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 486 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

486
Total Claims
$1.7M
Total Drug Cost
125
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
631
Total Day Supply
16,622
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$1.5M
Generic Drug Cost
$277K
Opioid Claims
44 (9.1% rate)
Antibiotic Claims
29

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
2.32
Gender Split
53% female / 47% male
Age Distribution
<65: 18, 65-74: 50, 75-84: 46, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GIAMPAOLO TALAMO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
39
Prochlorperazine Maleate
27
Abiraterone Acetate
26
Xarelto
Rivaroxaban
23
Dexamethasone
22
Ibrance
Palbociclib
14
Xtandi
Enzalutamide
14
Acyclovir
13
Anastrozole
13
Letrozole
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How GIAMPAOLO TALAMO, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

GIAMPAOLO TALAMO, MD's 486 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in District of Columbia

Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as TALAMO.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GIAMPAOLO TALAMO, MD's specialty?
GIAMPAOLO TALAMO, MD specializes in Medical Oncology Physician and practices in WASHINGTON, District of Columbia. Credentials: MD.
How much does GIAMPAOLO TALAMO, MD prescribe under Medicare Part D?
In 2023, GIAMPAOLO TALAMO, MD wrote 486 Medicare Part D claims totaling $1.7M in drug costs for 125 beneficiaries.
What is GIAMPAOLO TALAMO, MD's Medicare quality score?
GIAMPAOLO TALAMO, MD has a CMS MIPS Final Score of 82.9075/100 (Quality: 74.0928, Cost: 65.9443). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GIAMPAOLO TALAMO, MD located?
GIAMPAOLO TALAMO, MD is located at 5255 LOUGHBORO RD NW FL 1, WASHINGTON, DC, 20016. Phone: (202) 660-6500.
What is GIAMPAOLO TALAMO, MD's NPI number?
GIAMPAOLO TALAMO, MD's National Provider Identifier (NPI) is 1073540332, issued on 06/26/2006.
Does GIAMPAOLO TALAMO, MD prescribe more brand-name or generic drugs?
GIAMPAOLO TALAMO, MD's prescribing is 23% brand-name and 77% generic drugs by claim count, with $1.5M in brand drug costs.
Does GIAMPAOLO TALAMO, MD prescribe opioids?
Yes, GIAMPAOLO TALAMO, MD had 44 opioid claims in 2023 with an opioid prescribing rate of 9.1%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does GIAMPAOLO TALAMO, MD prescribe most often?
Based on 2023 Medicare Part D data, GIAMPAOLO TALAMO, MD's most frequently prescribed drugs include Prednisone, Prochlorperazine Maleate, Abiraterone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GIAMPAOLO TALAMO, MD accept Medicare?
GIAMPAOLO TALAMO, MD appears in CMS Medicare data with 486 Part D claims and 125 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GIAMPAOLO TALAMO, MD's credentials?
GIAMPAOLO TALAMO, MD's NPI is 1073540332 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology